News & Insights | Clinical & Medical Affairs

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

UK backs AI-generated placebo groups to speed drug trials

EU industry group says public-private partnerships are optimizing trial sector

PhRMA-backed Yale trial diversity program launches as nonprofit

CROs must embrace AI says PhaseV, following $50m funding round to expand platform

Julius merges with Peachtree Bioresearch to boost reach and CNS know-how

Curasight hires Premier Research for Phase I glioblastoma study

Digital twins could help patients get more from automated insulin delivery, study finds

US FDA plans to use AI to accelerate clinical trial reviews

ICON launches multi-indication trial design service for obesity drugs

EMA approves AI tool for biopsy analysis in liver disease trials

Crown Bioscience extends deal with NEXT Oncology

US FDA OKs QPS’ Phase I unit in Hyderabad after unscheduled inspection

Psyence Biomed hires Southern Star for Phase II psilocybin study

Strategic alliance: PSI CRO joins forces with Seoul’s Severance Hospital

Source Biosciences buys Cambridge Clinical Laboratories to expand clinical offering

MHRA reports high pharma investment in UK trials

WHO’s primary registry designation for CTIS a boost for EU trials, says EMA

Lindus receives UK funding for safe AI trial design optimization project

Calla Lily Clinical Care secures UK NIHR funding for progesterone device trial

Singapore’s GIC and Temasek join TPG as Novotech investors

Quick Links